AA
MYOK

ALPS Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

ALPS Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-70,988
Closed -$4.63M – 980
2018
Q3 		$4.63M Buy
70,988
+13,833
+24% +$813K 0.03% 169
2018
Q2 		$2.84M Buy
57,155
+9,219
+19% +$446K 0.02% 205
2018
Q1 		$2.34M Buy
47,936
+8,332
+21% +$433K 0.02% 200
2017
Q4 		$1.67M Buy
39,604
+5,179
+15% +$200K 0.01% 207
2017
Q3 		$1.48M Buy
34,425
+6,032
+21% +$192K 0.01% 210
2017
Q2 		$372K Buy
+28,393
New +$374K ﹤0.01% 695

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return